
    
      This study seeks to enroll patients receiving a Survivorship Care Plan following curative
      therapy for cancer. Participants will be randomly assigned to receive usual care or to be
      followed by a Patient Navigator as part of their Survivorship Care Plan.

      Study participation for all participants will be for up to 9 months, with study visits
      approximately every 3 months, based on standard clinical follow-up. All participants will be
      administered quality of life surveys by a Clinical Research Associate at study entry,
      mid-study (approximately 3-6 months) and at study completion.

      The following factors will be compared between arms:

        -  Missed/kept appointments

        -  Use of urgent/emergent care

        -  Quality of Life in relation to survivorship care

        -  Participants lost to care
    
  